These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 31870814

  • 1. Na+/K+ ATPase-targeted delivery to metastatic breast cancer models.
    Araste F, Abnous K, Hashemi M, Dehshahri A, Detampel P, Alibolandi M, Ramezani M.
    Eur J Pharm Sci; 2020 Feb 15; 143():105207. PubMed ID: 31870814
    [Abstract] [Full Text] [Related]

  • 2. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
    Kefayat A, Vaezifar S.
    Int J Biol Macromol; 2019 Sep 01; 136():48-56. PubMed ID: 31195043
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
    Alibolandi M, Sadeghi F, Abnous K, Atyabi F, Ramezani M, Hadizadeh F.
    Eur J Pharm Biopharm; 2015 Aug 01; 94():521-31. PubMed ID: 26170161
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications.
    Chai F, Sun L, He X, Li J, Liu Y, Xiong F, Ge L, Webster TJ, Zheng C.
    Int J Nanomedicine; 2017 Aug 01; 12():1791-1802. PubMed ID: 28424550
    [Abstract] [Full Text] [Related]

  • 8. PEGylated-PLGA Nanoparticles Coated with pH-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer.
    Hu F, Zhang R, Guo W, Yan T, He X, Hu F, Ren F, Ma X, Lei J, Zheng W.
    Mol Pharm; 2021 Jun 07; 18(6):2161-2173. PubMed ID: 32515968
    [Abstract] [Full Text] [Related]

  • 9. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P, Zhou Q, Zhu H, Zhuang Y, Bao J.
    BMC Cancer; 2020 Apr 28; 20(1):354. PubMed ID: 32345258
    [Abstract] [Full Text] [Related]

  • 10. CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice.
    Mondal L, Mukherjee B, Das K, Bhattacharya S, Dutta D, Chakraborty S, Pal MM, Gaonkar RH, Debnath MC.
    Int J Nanomedicine; 2019 Apr 28; 14():8073-8094. PubMed ID: 31632019
    [Abstract] [Full Text] [Related]

  • 11. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X, Wang J, Xu Y, Shao H, Gu J.
    Colloids Surf B Biointerfaces; 2019 Aug 01; 180():110-117. PubMed ID: 31030022
    [Abstract] [Full Text] [Related]

  • 12. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
    Li Z, Chen Q, Qi Y, Liu Z, Hao T, Sun X, Qiao M, Ma X, Xu T, Zhao X, Yang C, Chen D.
    Biomacromolecules; 2018 Jul 09; 19(7):2595-2609. PubMed ID: 29618203
    [Abstract] [Full Text] [Related]

  • 13. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
    Shafiei-Irannejad V, Samadi N, Salehi R, Yousefi B, Rahimi M, Akbarzadeh A, Zarghami N.
    Pharm Res; 2018 Apr 18; 35(6):119. PubMed ID: 29671072
    [Abstract] [Full Text] [Related]

  • 14. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
    Liu P, Chen N, Yan L, Gao F, Ji D, Zhang S, Zhang L, Li Y, Xiao Y.
    Carbohydr Polym; 2019 Jun 01; 213():17-26. PubMed ID: 30879657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N, Rahmani R, Paknejad M.
    Life Sci; 2020 Nov 15; 261():118361. PubMed ID: 32861796
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multifunctional PLGA nanoparticles combining transferrin-targetability and pH-stimuli sensitivity enhanced doxorubicin intracellular delivery and in vitro antineoplastic activity in MDR tumor cells.
    Scheeren LE, Nogueira-Librelotto DR, Mathes D, Pillat MM, Macedo LB, Mitjans M, Vinardell MP, Rolim CMB.
    Toxicol In Vitro; 2021 Sep 15; 75():105192. PubMed ID: 33984456
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.